// App-Quantinova.ai

TCT-825 : In-Vivo Long Term Evaluation of a Novel Mitral Valve Regurgitation Therapy: Experience in a Preclinical Large Animal Model

Researchers

Presenter

  • Athanasios Peppas

Principal Investigators

  • Jon Wilson

  • Yanping Cheng

  • Christopher Seguin

  • Masahiko Shibuya

  • Greg L Kaluza

  • Juan Granada

Medical Centers

  • Cardiovascular Research Foundation, Orangeburg, NY

Locations

  • United States

Companies

  • Cardiosolutions, Inc

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Mitral valve regurgitation

  • Tricuspid regurgitation

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Iopromide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved